Dupixent Receives CHMP Endorsement for Pediatric Eosinophilic Esophagitis Treatment in the EU
Sep 21, 2024
Sanofi Invest Information
Dupixent® (dupilumab) Receives U.S. Approval for Treating Chronic Rhinosinusitis with Nasal Polyps in Adolescents
Sep 14, 2024
Innovative COPD Therapy Dupixent Gains Approval in the EU, Marking a First for Targeted Treatment
Jul 4, 2024
Sanofi’s Dupixent Under FDA Priority Review for Adolescents with CRSwNP
May 14, 2024